SCHEMBL22978690

SCHEMBL22978690

C=CCCC(=O)c1cccnc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLOD2 O00469 2/20 0.56
HDAC1 Q13547 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
TBXAS1 P24557 9/20 0.50
GAA P10253 2/20 0.50
ALDH1A1 P00352 1/20 0.50
APP P05067 1/20 0.50
HCAR3 P49019 1/20 0.50
HCAR2 Q8TDS4 1/20 0.50
PLOD3 O60568 1/20 0.50
PLOD1 Q02809 1/20 0.50
CTNNB1 P35222 1/20 0.49
WNT3A P56704 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
F7 P08709 1/20 0.49
F3 P13726 1/20 0.49
SARM1 Q6SZW1 1/20 0.49
SIRT2 Q8IXJ6 1/20 0.49
SIRT6 Q8N6T7 1/20 0.49
SIRT1 Q96EB6 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2560518 0.85 PLOD2 (0.57) PLOD2HDAC1HDAC8TBXAS1GAA
SCHEMBL29623724 0.85 PLOD2 (0.57) PLOD2HDAC1HDAC8TBXAS1GAA
SCHEMBL7075878 0.84 PLOD2 (0.69) PLOD2HDAC1HDAC8TBXAS1GAA
SCHEMBL9488231 0.83 PLOD2 (0.59) PLOD2HDAC1HDAC8TBXAS1GAA
SCHEMBL16703059 0.81 PLOD2 (0.61) PLOD2HDAC1HDAC8TBXAS1GAA
SCHEMBL28631384 0.80 ALDH1A1 (0.50) TBXAS1GAAALDH1A1APPHCAR3
SCHEMBL9199313 0.79 PLOD2 (0.79) PLOD2HDAC1HDAC8TBXAS1GAA
SCHEMBL9405126 0.79 PLOD2 (0.62) PLOD2HDAC1HDAC8TBXAS1GAA
SCHEMBL21133737 0.79 PLOD2 (0.62) PLOD2HDAC1HDAC8TBXAS1GAA
SCHEMBL19043247 0.79 HDAC1 (0.60) PLOD2HDAC1HDAC8TBXAS1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114585622-B Piperidinyl-methyl-purinamines as NSD2 inhibitors and anticancer agents 诺华股份有限公司 2024-08-09 CN disclosed
EP-4013755-A1 PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS Novartis AG (CH) 2022-06-22 EP disclosed
CN-114585622-A Piperidinyl-methyl-purinamines as NSD2 inhibitors and anticancer agents 诺华股份有限公司 2022-06-03 CN disclosed
WO-2021026803-A1 PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS NOVARTIS AG (CH) 2021-02-18 WO disclosed